Abstract Background Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched patients who received either TACE. multimodal therapy or palliative care. Methods 95 patients seen at the department of Gastroente... https://foldlyers.shop/product-category/front-loader/